BGDO | Belgian Group of Digestive Oncology

  • Plein écran
  • Ecran large
  • Ecran étroit
  • Increase font size
  • Default font size
  • Decrease font size

The SIR-Step trial

E-mail Print PDF

A Randomized phase III trial comparing hepatic arterial injection of Yttrium-90 resin microspheres (SIR-spheres) plus systemic maintenance therapy versus systemic maintenance therapy alone for patients with unresectable liver metastases from colorectal cancer which are controlled after induction systemic therapy: the SIR-step trial.

EudraCT number: 2012-000508-14 - NCT 01895257

Start inclusion: Oct2013

Accrual period of 30 months and 12 months of follow-up




SIRSTEP newsletter 2

You are here: Clinical trial - registries The SIR-Step trial